398 related articles for article (PubMed ID: 17143815)
1. Recent updates on onchocerciasis: diagnosis and treatment.
Udall DN
Clin Infect Dis; 2007 Jan; 44(1):53-60. PubMed ID: 17143815
[TBL] [Abstract][Full Text] [Related]
2. Head nodding syndrome and river blindness: a parasitologic perspective.
Kaiser C; Pion S; Boussinesq M
Epilepsia; 2009 Oct; 50(10):2325-6. PubMed ID: 19785668
[No Abstract] [Full Text] [Related]
3. Onchocerciasis in a nonendemic population: clinical and immunologic assessment before treatment and at the time of presumed cure.
Henry NL; Law M; Nutman TB; Klion AD
J Infect Dis; 2001 Feb; 183(3):512-6. PubMed ID: 11133386
[TBL] [Abstract][Full Text] [Related]
4. Onchocerciasis in a teenager from Africa.
Leake JA; Pong AL; Scher CA; Newbury RO; Cunningham BB
Arch Dermatol; 2004 Sep; 140(9):1161-6. PubMed ID: 15381564
[No Abstract] [Full Text] [Related]
5. Genetic polymorphism of the beta-tubulin gene of Onchocerca volvulus in ivermectin naïve patients from Cameroon, and its relationship with fertility of the worms.
Bourguinat C; Pion SD; Kamgno J; Gardon J; Gardon-Wendel N; Duke BO; Prichard RK; Boussinesq M
Parasitology; 2006 Feb; 132(Pt 2):255-62. PubMed ID: 16197589
[TBL] [Abstract][Full Text] [Related]
6. Chemokines in onchocerciasis patients after a single dose of ivermectin.
Fendt J; Hamm DM; Banla M; Schulz-Key H; Wolf H; Helling-Giese G; Heuschkel C; Soboslay PT
Clin Exp Immunol; 2005 Nov; 142(2):318-26. PubMed ID: 16232219
[TBL] [Abstract][Full Text] [Related]
7. Ivermectin imposes selection pressure on P-glycoprotein from Onchocerca volvulus: linkage disequilibrium and genotype diversity.
Ardelli BF; Guerriero SB; Prichard RK
Parasitology; 2006 Mar; 132(Pt 3):375-86. PubMed ID: 16280093
[TBL] [Abstract][Full Text] [Related]
8. Genetic selection of low fertile Onchocerca volvulus by ivermectin treatment.
Bourguinat C; Pion SD; Kamgno J; Gardon J; Duke BO; Boussinesq M; Prichard RK
PLoS Negl Trop Dis; 2007 Aug; 1(1):e72. PubMed ID: 17989786
[TBL] [Abstract][Full Text] [Related]
9. [An itching disease from the tropics: onchocerciasis as an imported disease].
de Vries PJ; Kingma WP; Wetsteyn JC
Ned Tijdschr Geneeskd; 1994 Sep; 138(36):1793-8. PubMed ID: 7935904
[No Abstract] [Full Text] [Related]
10. Evaluation of onchocerciasis seroprevalence in Bioko Island (Equatorial Guinea) after years of disease control programmes.
Hernández-González A; Moya L; Perteguer MJ; Herrador Z; Nguema R; Nguema J; Aparicio P; Benito A; Gárate T
Parasit Vectors; 2016 Sep; 9(1):509. PubMed ID: 27645887
[TBL] [Abstract][Full Text] [Related]
11. Ivermectin resistance in Onchocerca volvulus: toward a genetic basis.
Lustigman S; McCarter JP
PLoS Negl Trop Dis; 2007 Aug; 1(1):e76. PubMed ID: 17989789
[No Abstract] [Full Text] [Related]
12. Seasonal biting pattern of Simulium damnosum s.l and its implications on onchocerciasis treatment with ivermectin.
Adewale B; Oyerinde JP; Mafe MA
West Afr J Med; 2008 Oct; 27(4):224-9. PubMed ID: 19469400
[TBL] [Abstract][Full Text] [Related]
13. Onchocerca volvulus-specific antibody and cytokine responses in onchocerciasis patients after 16 years of repeated ivermectin therapy.
Mai CS; Hamm DM; Banla M; Agossou A; Schulz-Key H; Heuschkel C; Soboslay PT
Clin Exp Immunol; 2007 Mar; 147(3):504-12. PubMed ID: 17302900
[TBL] [Abstract][Full Text] [Related]
14. Identification of the forest strain of Onchocerca volvulus using the polymerase chain reaction technique.
Adewale B; Mafe MA; Oyerinde JP
West Afr J Med; 2005; 24(1):21-5. PubMed ID: 15909705
[TBL] [Abstract][Full Text] [Related]
15. Status of forest onchocerciasis in the Lower Cross River Basin, Nigeria: change in clinical and parasitological indices after 6 years of ivermectin intervention.
Opara KN; Fagbemi BO; Atting IA; Oyene UE; Okenu DM
Public Health; 2007 Mar; 121(3):202-7. PubMed ID: 17241647
[No Abstract] [Full Text] [Related]
16. Immune responses directed against microfilariae correlate with severity of clinical onchodermatitis and treatment history.
Ali MM; Baraka OZ; AbdelRahman SI; Sulaiman SM; Williams JF; Homeida MM; Mackenzie CD
J Infect Dis; 2003 Feb; 187(4):714-7. PubMed ID: 12599094
[TBL] [Abstract][Full Text] [Related]
17. Onchocerciasis: developments in diagnosis, treatment and control.
Stingl P
Int J Dermatol; 2009 Apr; 48(4):393-6. PubMed ID: 19335425
[No Abstract] [Full Text] [Related]
18. Evidence for suppression of Onchocerca volvulus transmission in the Oaxaca focus in Mexico.
Rodríguez-Pérez MA; Lizarazo-Ortega C; Hassan HK; Domínguez-Vásquez A; Méndez-Galván J; Lugo-Moreno P; Sauerbrey M; Richards F; Unnasch TR
Am J Trop Med Hyg; 2008 Jan; 78(1):147-52. PubMed ID: 18187798
[TBL] [Abstract][Full Text] [Related]
19. Single nucleotide polymorphisms in β-tubulin selected in Onchocerca volvulus following repeated ivermectin treatment: possible indication of resistance selection.
Nana-Djeunga H; Bourguinat C; Pion SD; Kamgno J; Gardon J; Njiokou F; Boussinesq M; Prichard RK
Mol Biochem Parasitol; 2012 Sep; 185(1):10-8. PubMed ID: 22677339
[TBL] [Abstract][Full Text] [Related]
20. A rapid-format antibody card test for diagnosis of onchocerciasis.
Weil GJ; Steel C; Liftis F; Li BW; Mearns G; Lobos E; Nutman TB
J Infect Dis; 2000 Dec; 182(6):1796-9. PubMed ID: 11069258
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
